Pay in 4 interest-free payments of $5.35 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
At the end of the study, compared with those who took sulfonylureas, participants who continuously used GLP-1s over the 3-year period had the most pronounced risk reduction
Each batch of Dihexa undergoes rigorous quality control testing to ensure consistency, reliability, and suitability for research use
Stoicovy RA, Cora N, Perez A, Nagliya D, Del Calvo G, Lopez TB, et al
HPLC testing: High-performance liquid chromatography confirms peptide identity and purity
Evidence suggesting possible risk: rodent studies showed clear tumors GLP-1 receptors exist in human thyroid tissue GLP-1 drugs may influence calcitonin production isolated human case reports exist Evidence suggesting lower risk: humans have fewer GLP-1 receptors in thyroid tissue clinical trials did not show a statistically significant increase most cases are anecdotal or isolated The FDAs position: The risk cannot be ruled out
US$ 28.20
US$ 25.40
US$ 20.66
US$ 21.15
